These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3002247)

  • 1. Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis.
    Jones S; Yu VL; Johnson JT; Wagner RL; Kim HK
    Antimicrob Agents Chemother; 1985 Dec; 28(6):832-3. PubMed ID: 3002247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; van Noord JA
    J Antimicrob Chemother; 1984 Feb; 13(2):161-70. PubMed ID: 6323377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
    [No Abstract]   [Full Text] [Related]  

  • 4. Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
    Ball AP; Fox C; Ghosh D
    J Antimicrob Chemother; 1984 Oct; 14(4):395-401. PubMed ID: 6094422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bactericidal activity of sultamicillin in infants and children.
    Ginsburg CM; McCracken GH; Olsen K; Petruska M
    J Antimicrob Chemother; 1985 Mar; 15(3):345-51. PubMed ID: 2987174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sultamicillin (ampicillin-sulbactam) in the treatment of acute otitis media in children.
    Kaleida PH; Bluestone CD; Blatter MM; Reisinger KS; Wucher FP; Fall PA; Rohn DD
    Pediatr Infect Dis; 1986; 5(1):33-8. PubMed ID: 3003716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-way crossover study to compare the pharmacokinetics and acceptability of sultamicillin at two dose levels with that of ampicillin.
    Hartley S; Wise R
    J Antimicrob Chemother; 1982 Jul; 10(1):49-55. PubMed ID: 6286587
    [No Abstract]   [Full Text] [Related]  

  • 8. Sultamicillin--a new antibiotic in the treatment of persistent lower respiratory tract infections caused by Haemophilus influenzae.
    Pressler T; Pedersen SS; Christiansen L; Szaff M; Koch C; Høiby N
    J Antimicrob Chemother; 1986 Apr; 17(4):529-33. PubMed ID: 3011725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sultamicillin in the treatment of superficial skin and soft tissue infections in children.
    Goldfarb J; Aronoff SC; Jaffe A; Reed MD; Blumer JL
    Antimicrob Agents Chemother; 1987 Apr; 31(4):663-4. PubMed ID: 3038003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of sultamicillin in mice, rats, and dogs.
    English AR; Girard D; Haskell SL
    Antimicrob Agents Chemother; 1984 May; 25(5):599-602. PubMed ID: 6329091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study on sultamicillin and bacampicillin in the treatment of respiratory tract infections].
    Kobayashi H; Takamura K; Kono K; Nihei T; Saito A; Nakayama I; Ujiie A; Yajima O; Tango M; Tomizawa M
    Kansenshogaku Zasshi; 1985 Jul; 59(7):708-48. PubMed ID: 2997342
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
    Galante D; Esposito S; Barba D; Ruffilli MP
    J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
    Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
    Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.
    ROgers HJ; Bradbrook ID; Morrison PJ; Spector RG; Cox DA; Lees LJ
    J Antimicrob Chemother; 1983 May; 11(5):435-45. PubMed ID: 6307964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
    Campoli-Richards DM; Brogden RN
    Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two regimens of sultamicillin in treating uncomplicated gonorrhoea.
    Farthing C; Thin RN; Smith S; Phillips I
    Genitourin Med; 1985 Feb; 61(1):44-7. PubMed ID: 3002961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid.
    Emmerson AM; Cox DA; Lees LJ
    Eur J Clin Microbiol; 1983 Aug; 2(4):340-4. PubMed ID: 6313357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA; Campoli-Richards DM; Goa KL
    Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
    Hemsell DL
    Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
    English AR; Girard D; Cimochowski C; Faiella J; Retsema JA; Lynch JE
    Rev Infect Dis; 1986; 8 Suppl 5():S535-42. PubMed ID: 3026002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.